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Hematopoiesis requires the interaction of hemato-
poietic stem cells (HSCs) with various stromal
microenvironments. Here, we examine the role of
early B cell factor 2 (Ebf2), a transcription factor
expressed in a subset of immature osteoblastic cells.
Ebf2/ mice show decreased frequencies of HSCs
and lineage-committed progenitors. This defect is
cell nonautonomous, as shown by the fact that
transplantation of Ebf2-deficient bone marrow into
wild-type hosts results in normal hematopoiesis.
In coculture experiments, Ebf2/ osteoblastic cells
have reduced potential to support short-term prolif-
eration of HSCs. Expression profiling of sorted
Ebf2/ osteoblastic cells indicated that several
genes implicated in the maintenance of HSCs are
downregulated relative to Ebf2+/ cells, whereas
genes encoding secreted frizzled-related proteins
are upregulated. Moreover, wild-type HSCs cocul-
tured with Ebf2/ osteoblastic cells show a reduced
Wnt response relative to coculture with Ebf2+/ cells.
Thus, Ebf2 acts as a transcriptional determinant of an
osteoblastic niche that regulates the maintenance of
hematopoietic progenitors, in part by modulating
Wnt signaling.
INTRODUCTION
The hematopoietic system consists of multiple blood cell line-
ages that are derived from pluripotential hematopoietic stem
cells (HSCs) and multipotential and lineage-committed progen-
itor (LCP) cells. The maintenance of stem cells, which depends
on the balance between quiescence, proliferation, and differen-
tiation of cells, requires interactions with special microenviron-
ments, termed niches (Adams and Scadden, 2006; Kiel and
Morrison, 2008; Kincade et al., 1998; Li and Xie, 2005; Moore
and Lemischka, 2006; Suda et al., 2005). In the developing
mouse, HSCs arise in the yolk sac, the placenta, and the
aorta-gonad-mesonephros region. Later, they are found
predominantly in the fetal liver as themajor site of hematopoiesis496 Cell Stem Cell 7, 496–507, October 8, 2010 ª2010 Elsevier Inc.(Mikkola and Orkin, 2006). Before birth, HSCs are translocated
via the peripheral circulation to the developing bone marrow, in
which a subpopulation of bone-forming osteoblasts, termed
spindle-shaped, N-cadherin-positive osteoblasts (SNO), has
been implicated in constituting a niche for HSCs (Calvi et al.,
2003; Zhang et al., 2003). Osteoblasts have been found to
secrete factors that regulate the homeostasis of HSCs, including
angiopoietin, which promotes the maintenance of quiescent
HSCs (Arai et al., 2004), and the chemokine CXCL12 (Sugiyama
et al., 2006), which mediates stem cell trafficking.
In addition to the endosteal niche, perivascular cells and
mesenchymal progenitors are in contact with HSCs and have
been found to secrete angiopoietin and CXCL12 (Arai et al.,
2004; Kiel et al., 2005; Sacchetti et al., 2007; Sugiyama et al.,
2006). Both osteoblastic and endothelial cells can promote the
maintenance of HCSs in culture, and both stromal cell types
influence each other, which makes it difficult to attribute specific
functions to the endosteal and perivascular niches (Kiel and
Morrison, 2008). Moreover, a significant number of HSCs are
not localized adjacent to the endosteum and sinusoids, suggest-
ing that additional cells, including adiponectin-secreting adipo-
cytes, may contribute to the maintenance of HSCs in vivo
(DiMascio et al., 2007; Kiel et al., 2005). In contrast to the stem
cell niches that regulate the self-renewal and quiescence of
HSCs, other cellular microenvironments support the differentia-
tion of stem cells into specific hematopoietic lineages, such as
the B lymphocyte lineage (Tokoyoda et al., 2004).
In addition to cytokines and growth factors, Wnt signaling has
been implicated in the self-renewal of HSCs and the expansion
of lineage-committed progenitor cells (Malhotra and Kincade,
2009; Staal et al., 2008). The role of Wnt signaling in the homeo-
stasis of HSCs is complex because it involves the interplay
between canonical and noncanonical Wnt signaling pathways
and antagonists (Malhotra et al., 2008; Malhotra and Kincade,
2009). The canonical Wnt pathway is initiated by binding of
a subgroup of Wnt proteins, including Wnt3a, to Frizzled recep-
tors and Lrp5/6 coreceptors. As a consequence, b-catenin
accumulates and localizes to the nucleus where it associates
with members of the Lef1/Tcf family of transcription factors
and regulates the expression of target genes (Staal et al.,
2008). Noncanonical Wnt signaling, which is initiated by
a different group ofWnt proteins includingWnt5a, does not result
in b-catenin stabilization, but it can antagonize canonical Wnt
signaling (Murdoch et al., 2003; Nemeth et al., 2007). The
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lated by secreted antagonists. In particular, Dickkopf (Dkk)
proteins, which bind to the Lrp5/6 coreceptors, have been found
to modulate Wnt signaling in stem cell maintenance (Fleming
et al., 2008). Moreover, secreted Frizzled-related proteins (Sfrps)
bindWnt ligands and prevent the activation of the Frizzled recep-
tors (Bovolenta et al., 2008). Wnt proteins and their antagonists
have been found to be expressed by stromal cells and HSCs,
suggesting that HSCs may use the Wnt signaling pathways in
an autocrine and paracrine manner (Austin et al., 1997; Hackney
et al., 2002; Phillips et al., 2000).
In contrast to the extensively studied roles of signaling path-
ways in HSC homeostasis, much less is known about the func-
tion of transcription factors in this process. Early B cell (Ebf)
proteins represent a small family of highly conserved transcrip-
tion factors that include the founding member Ebf1, which is
expressed in B lymphocytes, osteoblasts, and adipocytes and
acts as a determinant of the B cell lineage (Hagman et al.,
1993; Jimenez et al., 2007; Lin and Grosschedl, 1995; Medina
et al., 2004). Another member of the family, Ebf2, is not
expressed in B lymphocytes, but is expressed more abundantly
in immature osteoblastic cells, adipocytes, and neurons (Garel
et al., 1997; Kieslinger et al., 2005; Malgaretti et al., 1997). The
expression of Ebf2 in immature osteoblastic cell raised the ques-
tion of whether this transcription factor plays a role in the stromal
support of hematopoiesis.
RESULTS
Ebf2 Is Expressed in Bone Marrow Stromal Cells
and Required for Normal Hematopoiesis
Ebf2 is expressed in immature osteoblastic cells of the bone
marrow (Kieslinger et al., 2005). To further characterize the
expression of Ebf2 at sites of hematopoiesis, we performed
RT-PCR and detected Ebf2 transcripts at low levels in bone
marrow (BM) and spleen (Figure 1A). In the thymus, the level of
Ebf2was higher and resembled that observed in brain as a posi-
tive control (Figure 1A). To visualize Ebf2-expressing cells in
lymphoid organs, we measured b-galactosidase (lacZ) activity
in tissue sections of Ebf2+/ mice, carrying one allele of an
in-frame insertion of the lacZ gene into the Ebf2 locus that
abrogates protein expression from the mutant allele (Corradi
et al., 2003). This analysis identified a small population of lacZ-
positive cells at the boundary between cortex and medulla of
the thymus and in the red pulp and marginal zone of the spleen
(Figures S1A and S1B available online). To examine whether
Ebf2 is expressed in hematopoietic cells, we sorted cells from
bone marrow, spleen, and thymus that are positive for the
pan-hematopoietic marker CD45 and analyzed the presence of
Ebf2 transcripts by RT-PCR. Ebf2 transcripts were detected
neither in RNA from CD45-positive cells nor in RNA from sorted
HSCs and common lymphoid progenitors (CLP; Figure 1A).
Ebf2-expressing cells represent immature osteoblastic cells
because they contain abundant transcripts of Runx2, express
Sox9 at a low level, and lack detectable transcripts of Osteocal-
cin (Kieslinger et al., 2005). To examine whether Ebf2 is also
expressed in the bone marrow vasculature, which has been
implicated in the function of hematopoietic niches (Kiel and
Morrison, 2008; Kiel et al., 2005), we isolated adherent cellsCfrom the long bones of Ebf2+/ mice and prepared RNA from
cells that have been sorted as positive or negative for the expres-
sion of Ebf2-lacZ.QuantitativeRT-PCRanalysis showeda similar
expression of CD31 (PECAM-1), a marker of endothelial cells, in
Ebf2-lacZ-positive and -negative cells (Figure 1B). In Ebf2-lacZ-
positive cells, the levels of Angiopoietin (Ang-1) and N-cadherin
were 4- and 20-fold higher, respectively (Figure 1B). By flow
cytometry, we found that N-cadherin is expressed in a small
subpopulation of Ebf2-lacZ-positive cells (Figure 1C). MECA-
32, a marker for endothelial cells that are located in close
proximity to immature hematopoietic cells (Kiel et al., 2005),
was detected in a subpopulation of Ebf2-negative, but not in
Ebf2-lacZ-positive, cells (Figure 1D). Thus, Ebf2 is expressed
in immature osteoblastic cells of the bone marrow that include
a small subpopulation of N-cadherin-expressing cells, but not
in endothelial or hematopoietic cells.
Impaired Lymphopoiesis in the Absence of Ebf2
Flow cytometry analysis to detect B220+CD43+ pre-B cells and
B220+CD43 B cells in 3-week-old mice indicated that both
cell populations are markedly reduced in Ebf2/ mice
(Figure 1E). In addition, the total number of thymocytes in
3-week-old Ebf2/ mice was reduced 6-fold, whereby the
frequency of CD4+CD8+ double-positive cells was decreased
relative to the frequencies of mature CD4+ and CD8+ single-posi-
tive cells (Figure 1F). The analysis of markers of cells in the
myeloid, granulocytic, erythroid, and NK lineages did not reveal
any significant changes in the mutant mice (Figure S1C and data
not shown). To determine whether the observed lymphoid
defects in Ebf2/ mice are due to changes in the stromal
environments of hematopoietic cells, we performed adoptive
transfer experiments of Ebf2/ bone marrow into lethally irradi-
ated C57Bl/6 mice. In this experiment, we could distinguish
Ebf2/ and Ebf2+/+ cells by the expression of the surface
markers CD45.2 and CD45.1, respectively. 3 to 4 months after
transplantation, the B cell populations in the bone marrow and
the thymic cell populations were similar in mice that have been
reconstituted with wild-type or mutant bone marrow (Figures
1G and 1H). Thus, the defects in lymphopoiesis in Ebf2/
mice are due to defects in the stromal environment.
Expression of Ebf2 could not be detected in the fetal liver, and
flow cytometric analysis of fetal B and T lymphopoiesis did not
reveal any significant defects in Ebf2/ mice (Figure S1D and
data not shown). We also determined the cellularities of hemato-
poietic cells in the bonemarrow, spleen, and thymus of wild-type
and mutant mice between 2 and 6 weeks after birth, before the
micedie for unknown reasons. In 3-week-oldEbf2/mice,which
are still healthy and have normal weight, we detected an approx-
imately 2-folddecreaseof hematopoietic cells in thebonemarrow
relative to wild-type mice and almost 6-fold decrease in both
spleen and thymus (Figure 1I). Therefore, the stromal defects
concern the adult, but not fetal, sites of hematopoiesis.
Reduced Numbers of Lineage-Committed Progenitors
and HSCs in Ebf2–/– Mice
To determine the frequencies of lineage-committed progenitors
in Ebf2/ bone marrow, we performed colony-forming assays
under conditions that detect precursors of various lineages.
In the mutant bone marrow, we observed a modest butell Stem Cell 7, 496–507, October 8, 2010 ª2010 Elsevier Inc. 497
Figure 1. Expression of Ebf2 in Stromal
Cells of the Bone Marrow and Cell-Nonau-
tonomous Hematopoietic Defect in Ebf2–/–
Mice
(A) RT-PCR analysis to detect the expression of
Ebf2 in hematopoietic organs and brain of adult
mice (left), in sorted hematopoietic stem cells
(HSCs), common lymphoid progenitor cells
(CLPs), and hematopoietic cells from various
organs (CD45+; right).
(B) Quantitative RT-PCR analysis to detect tran-
scripts of the indicated genes in sorted lacZ-ex-
pressing and nonexpressing cells that have been
isolated from long bones of Ebf2+/(lacZ) mice
under conditions to enrich for osteoblastic condi-
tions; n = 3. Error bars indicate SD of the mean,
and significance was determined by a two-tailed
t test.
(C) FACS analysis of cells isolated from long bones
under osteoblastic conditions. Ebf2-lacZ-positive
cells are analyzed for the surface expression of
N-cadherin.
(D) FACS analysis for CD31 andMECA-32 of Ebf2-
lacZ-negative (left) and -positive (right) cells from
Ebf2+/(lacZ) mice.
(E and F) FACS analysis of B lineage cells from
bone marrow (E) and T lineage cells from thymus
(F) of 3-week-old Ebf2+/+ and Ebf2/ mice.
(G and H) FACS analysis to detect B lineage cells
(G) and thymocytes (H) after bone marrow recon-
stitution. Lethally irradiated CD45.1 allelic mice
were used as hosts for the injection of 5 3 106
CD45.2 allelic Ebf2+/+ and Ebf2/ bone marrow
cells. Analysis was performed 3.5 months after
the adoptive transfer, and cells were gated as
positive for the expression of CD45.2. n = 5; repre-
sentative example is shown.
(I) Cellularities of thymus, spleen, and bone
marrow of Ebf2+/+ and Ebf2/ mice at different
postnatal time points. Cell numbers of single-cell
suspensions were determined and the highest
cell number for each wild-type organ was set as
100%. Cell numbers of the respective organs
were calculated as relative percentage (n = 3).
See also Figure S1.
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tors (CFU-E: 26%; BFU-E: 63%) and granulocytic/myeloid
progenitors (CFU-GM: 32%;CFU-M: 26%;CFU-G: 65%) relative
to wild-type bonemarrow (Figure 2A). However, the frequency of
Bcell progenitorswas reducedbya factor of 3.Wealsoexamined
the frequencies of hematopoietic progenitor cells that can recon-
stitute all lineages in a competitive bone marrow repopulation
assay by injecting mutant or wild-type cells at four dilutions
(1 3 104 to 3 3 105) into sublethally irradiated mice that retain
endogenous hematopoietic progenitors (Calvi et al., 2003; Zhang
et al., 2003). In this experiment, in which we also monitored the
engraftment over time, we observed a 2-fold decrease in the
number of long-term reconstitution units in the mutant versus
wild-type bone marrow (Figure 2B; Figure S2A). Consistent with498 Cell Stem Cell 7, 496–507, October 8, 2010 ª2010 Elsevier Inc.the results of the colony-forming assays, flowcytometric analysis
to detect c-Kit+Sca1+IL7R+ common lymphoid progenitor (CLP)
cells (Kondo et al., 1997) showed a 3- to 4-fold reduction in
mutant bone marrow relative to wild-type bone marrow. In
contrast, the numbers of multipotent progenitors (MPP),
including c-Kit+Sca1CD34+FcgRhi granulocyte/monocyte
progenitor (GMP), c-Kit+Sca1CD34+FcgRlo common myeloid
progenitor (CMP), and c-Kit+Sca1CD34FcgRlo megakaryo-
cyte/erythrocyte progenitor (MEP; Akashi et al., 2000), were rela-
tively unaffected (Figures 2C and 2D).
To extend our analysis to hematopoietic stem cells, we
analyzed HSCs by the surface expression of the SLAM cell
surface markers CD244, CD150, and CD48 (Kiel et al., 2005), by
the retention/efflux properties of cells that have been loaded
Figure 2. The Hematopoietic Defect in
Ebf2–/–Mice Affects Progenitor Cell Popula-
tions
(A) Analysis of the frequencies of hematopoietic
progenitor cells from 3-week-old mice by colony
assay (n = 3).
(B) Competitive bone marrow repopulation assay
with Ebf2+/+ and Ebf2/ bone marrow cells.
Sublethally irradiated CD45.1 allelic mice were
used as host for the injections of CD45.2 allelic
donor cells at four different concentrations (1 3
104, 3 3 104, 1 3 105, 3 3 105, n = 5 in each
case). Differences in the repopulating activities of
Ebf2+/+ and Ebf2/ cells were determined by
analyzing the frequencies of CD45.2+ cells (see
also Figure S2).
(C) Analysis of common lymphoid progenitors by
flow cytometry. IL7R+Lin cells were analyzed
for c-Kit and Sca1 in the lower two panels.
(D) FACS analysis of common myeloid progenitor
cells. Cells in the upper panels, gated for
c-Kit+LinSca1 cells, were analyzed for FcgR
and CD34 in the lower two panels.
(E and F) Flow cytometry of hematopoietic stem
cells.
(E) Upper panels: Analysis of HSCs via SLAM
markers. Cells in the analysis window were gated
as CD244-negative. Lower panels: Analysis of
HSCs by Hoechst dye efflux.
(F) Cells in the upper panels were gated as
c-Kit+Sca1+Lin cells and analyzed for CD34 and
CD150 expression in the lower panels.
(G and H) Analysis of fetal and adult HSCs.
(G) FACS analysis of bone marrow from 2-week-
old (upper panels) and 3-week-old (lower panels)
Ebf2+/+ and Ebf2/ mice. Cells were gated as
LinMac-1+ and analyzed for Sca1 and CD48.
(H) Comparison of fetal (LinMac-1+Sca1+CD48)
and adult (LinSca1+c-Kit+CD48) HSCs from
Ebf2+/+ mice (black bars) and Ebf2/ mice (gray
bars) over time (n = 3). See also Figure S2.
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Role of Ebf2 in the Hematopoietic Stem Cell Nichewith Hoechst dye (Goodell et al., 1996), and by the expression
of CD150 and CD34 on KSL (c-kithiSca1hilin) cells (Figures 2E
and 2F; Ema et al., 2006). In comparison to wild-type bone
marrow, Ebf2/ bone marrow displayed an approximately 3- to
4-fold reduction of the numbers of HSCs. To examine
whether the Ebf2/ bone marrow retains a fetal liver phenotype,
we performed a FACS analysis to detect fetal HSCs
(LinMac1+Sca1+CD48; Kimet al., 2007). In 3-week-oldEbf2/
mice, the frequency of HSCs presenting a fetal phenotype was
found to be increased relative to that detected in wild-type
mice, whereas the number of adult HSCswas decreased (Figures
2G and 2H). No difference in the frequencies of fetal HSC was
observed in the fetal liver of E16.5 wild-type and Ebf2-deficientCell Stem Cell 7, 496–507embryos (Figure S2B). Thus, the stromal
defect in Ebf2/ mice appears to affect
specifically the adult HSCs.
Role of Ebf2 in the Stromal Support
of HSCs In Vitro
Osteoblastic cells of the bone marrow
have been implicated in the generationof a niche that supports the maintenance of HSCs in vivo (Calvi
et al., 2003; Lo Celso et al., 2009; Xie et al., 2009; Zhang et al.,
2003). To examine whether immature hematopoietic cells and
Ebf2-expressing osteoblastic cells are in close contact, we
performed immunohistochemistry on sections of femurs of
E18.5 wild-type and Ebf2/ mice (Figure 3A). In the trabecular
bone region, Ebf2-lacZ-expressing immature osteoblastic cells
(green) that line the bonematrix were detected in close proximity
to Sca1-expressing hematopoietic progenitor cells (red), which
include HSCs and cells representing earliest stages of differenti-
ation.
Inactivation of the Ebf2 gene results in changes of the archi-
tecture of trabecular bone that include a decrease in mineral, October 8, 2010 ª2010 Elsevier Inc. 499
Figure 3. Reduced Activity of HSCs in Coculture with Ebf2–/– Osteo-
blastic Cells
(A) Immunohistochemistry of tibia from E18.5 Ebf2+/ mice. Sca1 is detected
by a-rat-Alexa546 (red), Ebf2-lacZ by a-rabbit-Alexa488 (green), and DNA
by TOPRO3 (blue). (I) Cancellous bone area. (II) Higher magnification of box
in I (rotated by 90).
(B) Coculture of sorted wild-type HSC-enriched KSL cells (c-Kit+Sca1+Lin) on
sorted Ebf2-lacZ+ osteoblastic cells from Ebf2+/mice (left) and Ebf2/mice
(right). Culture was performed in serum-free medium in the presence of low
amounts of IL3, IL6, and SCF. Pictures were taken after 10 days of coculture.
(C) Analysis of cobblestone area-forming cell frequencies (CAFC/well) after
10 days of coculture (n = 3 each).
(D) Analysis of colony formation ability (CFU-C) after 2 weeks of coculture as
described above (n = 3 each). Colonies in methylcellulose medium were
counted after 2 weeks.
(E) Limiting dilution analysis of HSC-enriched KSL cells cocultured on sorted
Ebf2+/ or Ebf2/ osteoblastic cells. KSL cells were seeded in different
numbers (0, 100, 200, 300, 400, 500, 600) in methylcellulose medium and
analyzed after 2 weeks of coculture. For each cell number, 15 wells were
analyzed. The percentage of wells containing no colonies is plotted against
the initial number of cells seeded into the wells (n = 20).
Scale bars represent 25 mm in (AI), 20 mm in (AII), 50 mm in (B).
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ation of osteoclasts (Kieslinger et al., 2005). To examine
whether Ebf2-deficient osteoblastic cells have a functional
defect in the maintenance of HSCs in vitro, we incubated
Ebf2+/ or Ebf2/ osteoblastic cells that have been sorted
for Ebf2-lacZ expression (Kieslinger et al., 2005) with wild-
type HSC-enriched KSL cells. The sorted KSL cells were cocul-
tured for 10 days in serum-free medium, supplemented with low
amounts of IL3, IL6, and SCF, and examined for the formation
of cobblestone areas (CA). CA colonies have been suggested
to derive from stem cells, and they have been proposed to500 Cell Stem Cell 7, 496–507, October 8, 2010 ª2010 Elsevier Inc.represent a primitive transplantable stem cell compartment
(Moore et al., 1997; Ploemacher et al., 1991). In coculture with
Ebf2/ osteoblastic cells, we observed a 45% reduction in
CA colonies, relative to cocultures with Ebf2+/ cells (Figures
3B and 3C). To further characterize the cells that form cobble-
stone areas, we transferred cells from the cocultures into meth-
ylcellulose medium and determined the ability of the cells to
give rise to colonies containing more than 50 cells after
5 days. The CA assay indicated that approximately 5.6 of
1000 cells have the ability to form colonies in coculture with
Ebf2+/ osteoblastic cells, whereas this frequency was reduced
to 3.1 of 1000 cells in coculture with Ebf2/ cells (Figure 3D).
After 10 days in coculture with Ebf2+/ osteoblastic cells, flow
cytometric analysis indicated that approximately 25% of the
hematopoietic cells maintained the KSL profile, relative to the
start of the culture (data not shown). Finally, we used a limiting
dilution assay to determine the frequency of cells that are able
to give rise to colonies in methylcellulose after 14 days of cocul-
ture. By determining the proportion of negative cultures in this
assay (Choong et al., 2003; Moore et al., 1997), we calculated
the frequency of colony-forming cells as 1 in 215 in cocultures
with Ebf2+/ cells and 1 in 330 in cocultures with Ebf2/ cells
(Figure 3E).
Ebf2 Augments HSC Maintenance In Vitro and Acts
Redundantly with Other Ebf Proteins
Few stromal cell lines have been shown to support HSCs and
progenitors in vitro. In particular, the stromal cell lines AFT024
and 2018, which have been generated from fetal liver by immor-
talization with SV40 T-antigen, support in vitro maintenance of
HSCs with high and low efficiency, respectively (Moore et al.,
1997). Microarray analysis aimed at detecting differences in
the expression of genes that may be involved in the support of
HSCs indicated that Ebf2 is differentially expressed in AFT024
and 2018 (Hackney et al., 2002). Quantitative RT-PCR indicated
that the level of Ebf2 expression in AFT024 cells is 20-fold higher
than that in 2018 cells (Figure 4A). To examine whether the
forced expression of Ebf2 in 2018 cells would augment the
in vitro maintenance of cocultured HSCs, we transduced 2018
cells with an Ebf2-GFP bicistronic retrovirus and performed an
immunoblot analysis to determine Ebf protein expression and
a CA assay to measure the stromal support (Figure 4B, upper
and lower panels). In coculture with Ebf2-transduced 2018 cells,
we observed a 2- to 3-fold increase in the formation of CA
colonies relative to mock-transduced 2018 cells (Figure 4B;
lower panel). However, we did not obtain the efficiency observed
with AFT024 cells, which was found to be similar to Ebf2-lacZ-
positive osteoblastic cells (Figure 4C and data not shown).
Ebf2 is highly conserved with three other members of the Ebf
family of transcription factors (Dubois and Vincent, 2001) and
therefore, we also examined the potential of Ebf1 and Ebf3 to
augment the stromal support of 2018 cells. Forced expression
of Ebf1 or Ebf3, which was detected by a monoclonal antibody
that recognizes all members of the Ebf family (a-panEbf), also
resulted in an increase in the stromal support of HSC-enriched
KSL cells by 2018 cells (Figure 4B). In contrast, overexpression
of Ebf1 or Ebf2 did not result in an increase in the stromal support
by AFT024 cells, whereas Ebf3 overexpression resulted in
a modest decrease of the stromal support (Figure 4C).
Figure 4. Redundancy of Ebf Family Members in
the Stromal Support of HSCs
(A) Quantitative RT-PCR analysis of Ebf2 in Ebf2-lacZ
sorted osteoblastic cells from Ebf2+/ mice, AFT024,
and 2018 stromal cells. Expression in Ebf2-lacZ sorted
cells is set to 1, and up- or downregulation is given as
fold difference (n = 3).
(B) Immunoblot analysis of 2018 cells infected with retrovi-
ruses encoding different Ebf proteins (upper panels) and
determination of CAFC activity after coculture of these
cells with wild-type HSC-enriched KSL cells (lower
panels).
(C) Immunoblot analysis and determination of CAFC
activity of retrovirus-infected AFT024 cells as described
above.
(D) Schematic representation of the retroviral construct
used for the concomitant downregulation of Ebf1, 2,
and 3. Two different constructs were used (RNAi-a,
RNAi-b), which differ in the sequences for the inhibition
of Ebf1, 2, and 3.
(E and F) Immunoblot analysis of Ebf2-lacZ expressing
osteoblastic cells from Ebf2+/ and Ebf2/mice infected
with retroviruses encoding the indicated siRNAs (upper
panels) and coculture of these cells with wild-type HSCs
(lower panels).
(G) Immunoblot analysis and coculture of infected AFT024
cells as described above. n = 3 for each CAFC shown in
(B)–(G). Error bars indicate SD of the mean, and signifi-
cance was determined by a two-tailed t test.
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of HSCs
The modest defect of Ebf2/ osteoblastic cells in supporting
hematopoiesis in vivo and in vitro raised the question of whether
Ebf2 acts redundantly with other members of the Ebf family; Ebf1
and Ebf3 transcription factors are also expressed in Ebf2-posi-
tive osteoblastic cells (Kieslinger et al., 2005). The inactivation
of Ebf1 results in a perinatal death, preventing the analysis of
Ebf1/Ebf2/ osteoblasts. Therefore, we generated a GFP
retroviral construct that allows for the concomittant expression
of Ebf1-, Ebf2-, and Ebf3-specific siRNAs, with the RNAi flanking
region of miR155 (Figure 4D; Chung et al., 2006). We generated
different siRNA constructs and found that two constructs,
termed RNAi-a and RNAi-b, downregulated total Ebf proteinCell Stem Cell 7, 4expression (Ebf1+Ebf2+Ebf3) in various cells,
as determined by immunoblot analysis with
the a-pan-Ebf antibody (Figures 4E–4G). In
these experiments, siRNA construct b was
more efficient in the downregulation of Ebf
proteins than construct a. In a CA assay, we
found that the transduction of sorted
Ebf2+/lacZ-positive osteoblasts with the
siRNA b construct reduced the stromal support
of HSC-enriched KLS cells by a factor of 4
(Figure 4E). We also examined the effects of
siRNA-mediated combined downregulation of
Ebf protein expression in Ebf2/lacZ-positive
osteoblasts and observed a stronger decrease
in the stromal support of HSC-enriched KSL
cells than that observed with knockdown of
Ebf1 or Ebf3 alone (Figure 4F). Moreover, thecombined knockdown of Ebf1, Ebf2, and Ebf3 in AFT024 cells
impaired stromal support by a factor of 4 to 5 (Figure 4G). Trans-
duction of 2018 cells with the siRNA construct affected only
modestly the formation of CA colonies (data not shown). Taken
together, these results suggest that Ebf proteins act redundantly
in the support of immature hematopoietic cells in vitro and that
the expression of Ebf proteins is an important, but not sufficient,
determinant in this process.
Identification of Ebf2 Target Genes
With the aim of identifying genes that are differentially
expressed in Ebf2+/ and Ebf2/ osteoblasts, we sorted these
cells for lacZ expression and performed a microarray analysis.
In Ebf2/ cells, several genes were found to be down- or96–507, October 8, 2010 ª2010 Elsevier Inc. 501
Figure 5. Ebf2-Regulated Genes Have
a Role in the Stromal Support of Immature
Hematopoietic Cells
(A and B) Quantitative RT-PCR analysis to detect
transcripts that are differentially regulated (see
also Table S1) in sorted osteoblastic cells of
Ebf2+/ and Ebf2/mice (n = 3 each). Expression
of the indicated genes was set to 1 in wild-type
mice, and upregulation (A) or downregulation
(B) in Ebf2/ cells is given as fold-difference.
(C) Quantitative RT-PCR analysis of the indicated
genes in 2018 cells and in 2018 cells that have
been transduced with an Ebf2-expressing retro-
virus (n = 3).
(D and E) Coculture of wild-type HSC-enriched
KSL cells on Ebf2-lacZ-expressing osteoblastic
cells from Ebf2+/ and Ebf2/ mice that have
been infected with bicistronic retroviruses, encod-
ing the indicated genes and the red fluorescent
protein (dsRed) gene. Infected cells were sorted
for the expression of Ebf2-lacZ and dsRed.
(D) Analysis of cobblestone area forming cell
frequencies (CAFC/well) after 10 days of coculture
(n = 3).
(E) Analysis of colony formation ability (CFU-C)
after 2 weeks of coculture in methylcellulose
medium (n = 3). Error bars indicate SD of the
mean, and significance was determined by
a two-tailed t test.
See also Figure S3.
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(Table S1). Among the downregulated genes, we identified Pro-
liferin, encoding a secreted ligand of the insulin-like growth
factor receptor that has been implicated in the self-renewal of
HSCs (Choong et al., 2003). Additional downregulated genes
included osteoprotegerin, encoding a RANK decoy receptor
that we have previously identified as a direct target of Ebf2 in
osteoblasts (Kieslinger et al., 2005). Several genes were upregu-
lated in Ebf2/ cells, including secreted frizzled-related proteins
(Sfrp1 and Sfrp2; Table S1). To confirm and quantify the altered
expression of these and other genes identified in the microarray
analysis, we performed quantitative RT-PCR on three different
osteoblastic cell preparations from Ebf2+/ and Ebf2/ mice.
In Ebf2/ cells, the expression of Proliferin was reduced by
a factor of 7, whereas the expression of Sfrp1 and Sfrp2 was
increased 3.5- and 8-fold, respectively (Figures 5A and 5B).
Moreover, we found that the forced expression of Ebf2 in 2018
cells augmented the expression of Proliferin 5.2-fold and
reduced the expression of Sfrp1 and Sfrp2 by a factor of 3.1-
and 9.6-fold, respectively (Figure 5C). Finally, we performed
in situ hybridization and immunohistochemistry and found that
the cells expressing these genes are localized immediately adja-
cent to the bone matrix (Figure S3).
Modulation of Wnt Signaling in HSCs by Ebf2 Expression
in Osteoblastic Cells
Although Wnt signaling has been implicated in the maintenance
of HSCs, the relative contributions of the canonical versus non-
canonical pathways remain controversial (Malhotra et al., 2008;
Reya et al., 2003). Therefore, we examined whether the upregu-502 Cell Stem Cell 7, 496–507, October 8, 2010 ª2010 Elsevier Inc.lation of Sfrp1 and Sfrp2 in Ebf2/ osteoblastic cells has an
influence on the maintenance and/or Wnt responsiveness of
hematopoietic progenitor cells. To this end, we infected Ebf2-
lacZ-positive osteoblastic cells with a retrovirus encoding either
Ebf2, Proliferin, Sfrp1, or Sfrp2 coupled to red fluorescent
protein (Rfp) via a bicistronic mRNA, and we purified double-
positive cells by flow cytometry. In a CA assay, Ebf2- or Prolif-
erin-expressing Ebf2/ osteoblastic cells supported wild-type
HSCs almost as well as vector-transduced Ebf2+/ cells
(Figure 5D). No significant change of HSC support was observed
with Ebf2- or Proliferin-transduced Ebf2+/ cells, whereas the
cobblestone-forming ability of Sfrp2-transduced Ebf2+/ and
Sfrp2-transduced Ebf2/ cells was reduced (Figure 5D).
We also determined the effects of forced expression of Ebf2,
Proliferin, and Sfrp2 on the frequencies of colony-forming cells
(CFU-C). The frequency of CFU-C in coculture with vector-trans-
duced Ebf2/ osteoblastic cells was 3.8/1000 (Figure 5E). The
frequency of CFU-C of Ebf2-, Proliferin-, and Sfrp2-transduced
Ebf2/ osteoblastic cells was 5.8/1000, 4.8/1000, and 3.1/
1000, respectively. Thus, the expression of Proliferin overcomes,
in part, the defect of Ebf2/ osteoblasts in supporting HSCs,
whereas the overexpression of Sfrp2 osteoblasts further
augments the defect.
Second, we examined the expression of the Wnt target gene
Axin2 in HSC-enriched KLS cells from Ebf2+/ and Ebf2/
mice. Quantitative RT-PCR analysis of RNA from sorted KLS
cells revealed a 12-fold decrease of Axin2 expression in Ebf2/
cells relative to Ebf2+/ cells (Figure 6A). In Ebf2/ KLS cells, we
also detected a modest 2- to 3-fold downregulation of the
Notch1 and HoxB4 genes that have been previously implicated
Figure 6. Deletion of Ebf2Results in Altered
Wnt Responsiveness of HSC-Enriched KSL
Cells
(A) Quantitative RT-PCR analysis of Axin2, HoxB4,
and Notch1 transcripts in sorted KSL populations
of Ebf2+/+ and Ebf2/ mice (n = 3).
(B) Sorted HSC-enriched KSL cells were infected
with a lentiviral reporter containing Lef1/Tcf-
binding sites (Top-dGFP) linked to destabilized
Gfp and cocultured onEbf2-lacZ-expressing oste-
oblastic cells from Ebf2+/ and Ebf2/ mice
(lower panels). As a control, HSCs infected with
a lentiviral reporter containing mutated Lef1/Tcf-
binding sites (Fop-dGFP) or uninfected HSCs
were used for coculture (upper panels; n = 3 each).
(C) Model for the role of Ebf2 in HSC-supporting
niche cells. IEO, immature Ebf2-positive osteo-
blastic cell.
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addressed the question of whether the increased expression of
Sfrp genes in Ebf2/ osteoblastic cells modulates the Wnt
response in cocultured HSCs.We isolated Ebf2-lacZ-expressing
osteoblastic cells from Ebf2+/ and Ebf2/mice and cocultured
them with wild-type HSC-enriched KLS cells that have been
transduced with a Wnt-responsive reporter construct (TOP-
dGFP; Reya et al., 2003). In coculture with Ebf2/ osteoblastic
cells, we observed an approximately 3-fold decrease in the GFP-
positive cells, as compared to coculture with Ebf2+/ cells
(Figure 6B, bottom). No significant numbers of GFP-positive
cells were detected in uninfected HSCs or in HSCs that had
been transduced with a Fop-dGFP reporter construct containing
mutated Wnt response elements (Figure 6B, top). Thus, the
defect of Ebf2/ osteoblastic cells may, at least in part, be ac-
counted for by the upregulation of Sfrp genes and a decreased
Wnt response in HSCs (Figure 6C).
DISCUSSION
Our study suggests that Ebf2 is required for the proper stromal
support of hematopoietic progenitor cells in vivo and in vitro.
Determination of the frequencies of HSCs by competitive recon-
stitutions and flow cytometric analysis indicated that Ebf2-defi-
cient mice have a 2- to 4-fold decrease of the numbers of
HSCs as compared to wild-type mice. In principle, the decrease
in the numbers of HSCs in Ebf2/ bone marrow could be
accounted for by distinct stromal defects, including the homing
of cells to the bone marrow, cell adhesion, differentiation, and
the balance of proliferation and quiescence. The observation
that the potential to support HSCs in short-term coculture exper-Cell Stem Cell 7, 496–507iments is 2-fold lower in sorted Ebf2/
osteoblastic cells, as compared to
Ebf2+/ cells, argues against a defect in
homing. Moreover, the expression of
CXCL12, which is involved in homing of
progenitor cells (Hattori et al., 2003), is
normal in homozygous mutant osteo-
blastic cells (data not shown). Although
the altered proliferation of HSC-enrichedKSL cells and the reduced CAFC formation on Ebf2-deficient
osteoblastic cells suggest a defect in the bone marrow niche
of Ebf2/ mice, the CAFC assay does not necessarily reflect
niche functions. Assessment of in vivo niche function would
require a transfer of wild-type bone marrow cells into Ebf2/
mice, which has not been possible because of their lethality
between 6 and 8 weeks after birth.
The expression of Ebf2 in stromal cells of the bone marrow but
not fetal liver is consistent with the lack of a hematopoietic
phenotype in fetal liver. Differences in fetal versus adult hemato-
poiesis involve not only stromal cells, but also the HSCs them-
selves (Kikuchi and Kondo, 2006). Fetal and adult HSCs differ
in their stem cell properties, reconstitution potential, and
molecular markers (Kim et al., 2007, 2009). Interestingly, we
found that the numbers of HSCs representing an adult surface
phenotype are reduced in Ebf2-deficient bone marrow, whereas
HSCs with a fetal phenotype are not affected. Therefore, the
expression of Ebf2 in bone marrow stroma may affect the switch
of fetal to adult HSCs.
We have previously shown that Ebf2-deficient long bones
have an altered bone mass and trabecular structure, which can
be accounted for by an increased number of bone-degrading
osteoclasts and a downregulation of the expression of the
RANK decoy receptor gene Opg in osteoblasts (Kieslinger
et al., 2005). However, the numbers of osteoblasts and the rate
of bone formation were found to be normal in Ebf2/ mice
(Kieslinger et al., 2005). The bone defect in Ebf2-deficient mice
may explain the reduced cellularity of the bone marrow, but it
cannot account for the reduced stromal support of hematopoi-
etic progenitors in vitro. Therefore, the Ebf2-deficient osteo-
blastic cells appear to have at least two functional defects, one, October 8, 2010 ª2010 Elsevier Inc. 503
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clasts and the other related to the stromal support of hematopoi-
etic progenitor cells. Interestingly, osteoblasts have been impli-
cated in the support of hematopoietic progenitors through the
production of secreted and membrane-bound growth factors
(Suda et al., 2005; Taichman, 2005). In particular, an increase
in the numbers of osteoblastic cells in mice with a conditional
inactivation of the bone-morphogenetic protein receptor
(Bmpr-1a) or in mice overexpressing the parathyroid hormone-
related protein receptor parallels an increase in the numbers of
HSCs (Calvi et al., 2003; Zhang et al., 2003).
Previous comparison of stromal cell lines that support or do
not support HSC self-renewal revealed that Ebf2 transcripts
are more abundant in the HSC-supporting cell line AFT024, rela-
tive to the nonsupporting line 2018 (Hackney et al., 2002).
Notably, we found that the forced expression of Ebf2 in 2018
cells augments their stromal support in CA assays. Although fetal
stromal cells do not normally express Ebf2, the expression of
Ebf2 in AFT024 cell line may be related to the transformation
with SV40. In addition to the stromal cells in the bone marrow,
we also detect Ebf2-lacZ expression in some as yet uncharacter-
ized stromal cells of the spleen and thymus, which may account
for the marked defect in these lymphoid compartments.
In our analysis of genes that are differentially expressed in
osteoblastic cells from Ebf2+/ and Ebf2/ mice, we identified
Proliferin as a downregulated gene in Ebf2-deficient cells. The
Proliferin family of glycoproteins is related to the prolactin family
of peptide hormones that act as ligands for insulin type II recep-
tors and have cell growth-promoting activity (Choong et al.,
2003). Proliferin has been identified in a microarray screen for
genes that are upregulated in stromal cell lines supporting imma-
ture hematopoietic cells, and it has been implicated in the ex vivo
expansion of HSCs (Choong et al., 2003). Consistent with these
findings, Proliferin is not only downregulated in Ebf2-deficient
osteoblastic cells, but its forced expression in Ebf2/ osteo-
blastic cells can influence their stromal activity in coculture
with wild-type hematopoietic progenitor cells. In addition, we
identified adiponectin as a gene that is upregulated in Ebf2/
mice. Adiponectin, a protein that is secreted from adipocytes,
has been recently identified as a factor involved in the support
of HSCs (DiMascio et al., 2007). Therefore, it is likely that Ebf2-
expressing cells consist of several cell types, including cells of
the osteoblast and adipocyte lineages, and possibly mesen-
chymal progenitor cells that support the maintenance of HSCs
by different mechanisms.
Another interesting set of target genes are the Srfp-1 and -2
genes, which are upregulated in Ebf2/ osteoblastic cells.
Both Sfrp proteins antagonize canonical and noncanonical Wnt
signaling and thus modulate pathways implicated in the mainte-
nance of HSCs (Bovolenta et al., 2008; Malhotra and Kincade,
2009; Staal et al., 2008; Fleming et al., 2008; Renstrom et al.,
2009). Although the role of the canonical Wnt pathway in the
maintenance of hematopoietic cells has been extensively
studied, various loss- and gain-of-function experiments of b-cat-
enin did not yield reciprocal results (Austin et al., 1997; Baba
et al., 2006; Duncan et al., 2005; Jeannet et al., 2008;
Kirstetter et al., 2006; Koch et al., 2008; Murdoch et al., 2003;
Reya et al., 2003; Scheller et al., 2006). Moreover, the effects
of Wnt signaling in hematopoiesis may be subtle because504 Cell Stem Cell 7, 496–507, October 8, 2010 ª2010 Elsevier Inc.a deficiency of Wnt3a or a blockage of Wnt signaling by osteo-
blast-specific overexpression of a Dkk transgene reveals HSC
defects only in secondary transplantations (Fleming et al.,
2008; Luis et al., 2009). In the Dkk overexpression experiments,
Wnt signaling was shown to regulate the quiescence of HSCs
and the maintenance of the reconstitution function (Fleming
et al., 2008). A similar phenotype is observed in Sfrp1/ mice
whereby engraftment is increased in primary recipients but
decreased in secondary recipients (Renstrom et al., 2009).More-
over, Sfrp1/ stromal cells are more efficient in the support of
hematopoietic progenitors in vitro (Renstrom et al., 2009).
Sfrps act as negative regulators of both canonical and nonca-
nonical Wnt signaling by binding directly to Wnt proteins and
preventing their interaction with membrane-bound Frizzled
receptors (Bovolenta et al., 2008). However, the antagonistic
function of Sfrps is context dependent; they can also act as
Wnt agonists (Yokota et al., 2008). Consistent with the upregula-
tion ofSfrp1 and Sfrp2 genes in Ebf2-deficient osteoblastic cells,
we detected a decrease in the numbers of adult HSCs in Ebf2/
bone marrow and a reduced maintenance of HSCs in coculture
with Ebf2/ osteoblastic cells. The reduced activity of a trans-
duced Wnt-responsive reporter construct in HSCs that have
been cocultured with Ebf2/ stromal cells may be a conse-
quence of the upregulation of Sfrp1 and Sfrp2 in Ebf2/ osteo-
blastic cells. However, Wnt-dependent reporters can also be
triggered by non-Wnt ligands (Barolo, 2006). Moreover, we find
a downregulation ofNotch1 in Ebf2/HSCs, which is consistent
with the reported upregulation of the Notch1 target Hes1 in
Srfp1-deficient hematopoietic progenitors (Renstrom et al.,
2009). However, Notch1 deficiency does not affect hematopoi-
esis (Maillard et al., 2008). Therefore, we favor the view that the
defect of hematopoiesis in Ebf2/ mice reflects, at least in
part, a Sfrp-mediated alteration of Wnt signaling in the stromal
compartment. Although the role of Wnt signaling in HSCs is still
controversial, increasing evidence suggests a requirement of
b-catenin in bone marrow stromal cells for the maintenance
and adhesion of primitive hematopoietic cells (Kim et al., 2009;
Nemeth et al., 2009). The specific role of Ebf2 in adult hemato-
poiesis may also reflect differences in the responsiveness of fetal
versus adult HSCs to the expression of various signaling
agonists or antagonist that are regulated by Ebf2 and known to
affect HSC homeostasis (Morrison et al., 1995; Phillips et al.,
2000).
The Ebf protein family is highly conserved from C. elegans and
Drosophila to mouse and man (Dubois and Vincent, 2001). The
Drosophila ortholog of Ebf2, collier, has been recently implicated
in the stromal support of hematopoiesis (Crozatier et al., 2004;
Krzemien et al., 2007; Mandal et al., 2007). A discrete cluster
of cells in the Drosophila lymph gland, termed the posterior
signaling center (PSC), expresses collier and has been proposed
to resemble the stromal microenvironments in mammalian
hematopoietic organs (Crozatier et al., 2004; Lebestky et al.,
2003). The PSC regulates the balance between the maintenance
of quiescent prohemocytes and the differentiation of these cells
into mature hemocytes, including macrophage-like plasmato-
cytes and lamellocytes. Notably, collier is required for hemato-
poiesis in a cell-nonautonomous manner, and it endows PSC
cells with the capacity either to maintain hematopoietic progen-
itor cells and/or to induce their differentiation into lamellocytes
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Ebf proteins in the stromal support of hematopoiesis may be
evolutionary more ancient than the role of Ebf1 in the specifica-
tion and differentiation of B lineage cells.
EXPERIMENTAL PROCEDURES
PCR, RT-PCR, and Quantitative RT-PCR
Analysis of the Ebf2mutation was carried out in the C57Bl/6 strain of mice; all
animals used for this study were healthy and showed normal body weight.
Genotyping of Ebf2 mutant animals was performed as described (Corradi
et al., 2003). RT-PCR was carried out according to standard protocols. Quan-
titative RT-PCR was performed with SYBR GREEN PCR master mix (Applied
Biosystems) and the ABI PRISM 7000 sequence detection system. Sequences
for primer pairs are presented in Supplemental Information. Three independent
measurements were performed for each PCR analysis. The comparative CT
method was used to calculate the expression levels of RNA transcripts, and
the individual RNA expression levels were normalized to the expression of
b-actin. Error bars represent the standard deviation of themean of three exper-
iments.
Isolation and Cultivation of Cells and Lentiviral and Retroviral
Infection
Preparation of osteoblastic cells from embryonic and neonate bone was per-
formed as described (Kieslinger et al., 2005). For coculture experiments, cells
were isolated under osteoblastic conditions from embryonic leg (E18.5) and
2000 cells were sorted as Ebf2-lacZ positive into each well of a 96-well
plate. Cells were allowed to expand to 90% confluency, and sorted KSL
(LinSca1hic-kithi) immature hematopoietic cells were used for coculture under
serum-free conditions (StemPro SFM, Invitrogen) in the presence of recombi-
nant SCF (15 ng/ml), IL3 (5 ng/ml), and IL6 (5 ng/ml). Medium was partially
changed twice a week. After 10 days of coculture, photomicrographs were
taken and after 14 days cobblestone-area-forming cells were counted.
To determine CFU-C activity, cells were isolated via trypsin, sorted for the
expression of CD45, and seeded into methylcellulose medium (Arai et al.,
2004). After 10 days of culture, colony numbers were determined, and the
frequencies of CFU-C/total cell number were calculated. Lentiviral infections
of HSC with control or Wnt-responsive reporter viruses were performed as
described (Reya et al., 2003). For retroviral infections of osteoblastic cells,
Ebf1, -2, or -3were cloned into an MSCV-IRES-GFP retroviral vetor. Proliferin,
Sfrp1, and Sfrp2 were cloned into a MSCV-irDsRed vector (gift of Kevin D.
Bunting). LTC-IC assays were carried out as described (Choong et al., 2003;
Ploemacher et al., 1991), via sorted HSCs and sorted Ebf2-lacZ-expressing
osteoblastic cells from Ebf2+/ and Ebf2/ mice.
RNAi
For the downregulation of Ebf proteins by RNAi, the BLOCK-iT miR RNAi
expression vector kit (Invitrogen) was used to clone short-hairpin DNA directed
against the three Ebf genes into the vector pcDNA6.2-GW/EmGFP-miR. For
the production of retroviruses, the IRES-GFP site of pMSCV was removed
and the sequence containing the short hairpins plus the EmGfp were cloned
into the pMSCV. The sequences used for the RNAi constructs are presented
in Supplemental Information. Overexpression and downregulation of Ebf
proteins were determined by immunoblot analysis with Ebf antibody (clone
6G6).
Statistics
p values were determined with the Student’s two-tailed t test for independent
samples, assuming equal variances on all experimental data sets.
Generation of Bone Marrow Reconstituted Mice and Competitive
Reconstitution
CD45.1 (Ly5.1; Ptprc) C57Bl/6 mice were purchased from Jackson Labs
(Boston, MA) and lethally irradiated with 960 rad, given as a split dose
(Gammacell 40, MDS Nordion). Ebf2+/+ and Ebf2/ bone marrow was
isolated, and 500,000 cells were injected into the tail vein of irradiated host
animals. Wild-type C57/Bl6 bonemarrow cells and PBSwere injected as posi-Ctive and negative controls, respectively; in each case, five animals were used.
Analysis was carried out between 3 to 4 months after injection, with CD45.2-
specific antibodies to gate for donor-derived cells, because the Ebf2mutation
is in a CD45.2 (Ly5.2) C57Bl/6 background.
Competitive reconstitution was performed as described (Zhang et al., 2003).
In brief, CD45.1 C57Bl/6 mice were sublethally irradiated with a dose of 480
rad, and CD45.2-expressing bone marrow cells from Ebf2+/+ and Ebf2/
mice were injected at four different concentrations (1 3 104, 3 3 104, 1 3
105, 3 3 105) into the irradiated host animals. PBS was injected as negative
control and WT C57Bl/6 bone marrow cells were injected at the given concen-
trations as positive control. In each case, five animals were used for the adop-
tive transfer. 3 to 4 months after injection, analysis was carried out with
CD45.1- and CD45.2-specific antibodies to determine the contribution of
donor-derived cells; frequency and fold differences were calculated with
L-calc software (Stem Cell Technologies).ACCESSION NUMBERS
The Affymetrix microarray data are available in the Gene Expression Omnibus
(GEO) database under the accession number GSE21700.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and one table and can be found with this article online at
doi:10.1016/j.stem.2010.07.015.ACKNOWLEDGMENTS
We thank Dr. T. Reya for providing lentiviral vectors. We are grateful to I. Falk,
R. Istvanffy, and R. Oostendorp for help with FACS analysis and B. Ksienzyk,
C. Buske, M. Feuring-Buske, J. Ellwart, and K. Nispel for FACS sorting. We
thank V. Erben and C. Petritsch for help with confocal microscopy. This
work was supported by funds of the Max Planck Society and grants of the
Bavarian research foundation (Forimmun, T1) and German Research Founda-
tion (TRR54 and SFB620). Author contributions: M.K. performed most of the
experiments; S.H. performed the experiments in Figure 4 and G.D. performed
the microarray analysis shown in Table S1; G.G.C. provided the Ebf2+/ mice
and performed the immunohistochemistry shown in Figure S3; and R.G.
supervised the study and wrote the manuscript.
Received: October 9, 2009
Revised: May 14, 2010
Accepted: July 27, 2010
Published: October 7, 2010REFERENCES
Adams, G.B., and Scadden, D.T. (2006). The hematopoietic stem cell in its
place. Nat. Immunol. 7, 333–337.
Akashi, K., Traver, D., Miyamoto, T., and Weissman, I.L. (2000). A clonogenic
commonmyeloid progenitor that gives rise to all myeloid lineages. Nature 404,
193–197.
Arai, F., Hirao, A., Ohmura, M., Sato, H., Matsuoka, S., Takubo, K., Ito, K., Koh,
G.Y., and Suda, T. (2004). Tie2/angiopoietin-1 signaling regulates hematopoi-
etic stem cell quiescence in the bone marrow niche. Cell 118, 149–161.
Austin, T.W., Solar, G.P., Ziegler, F.C., Liem, L., and Matthews, W. (1997).
A role for the Wnt gene family in hematopoiesis: expansion of multilineage
progenitor cells. Blood 89, 3624–3635.
Baba, Y., Yokota, T., Spits, H., Garrett, K.P., Hayashi, S., and Kincade, P.W.
(2006). Constitutively active beta-catenin promotes expansion of multipotent
hematopoietic progenitors in culture. J. Immunol. 177, 2294–2303.
Barolo, S. (2006). Transgenic Wnt/TCF pathway reporters: All you need is Lef?
Oncogene 25, 7505–7511.ell Stem Cell 7, 496–507, October 8, 2010 ª2010 Elsevier Inc. 505
Cell Stem Cell
Role of Ebf2 in the Hematopoietic Stem Cell NicheBovolenta, P., Esteve, P., Ruiz, J.M., Cisneros, E., and Lopez-Rios, J. (2008).
Beyond Wnt inhibition: New functions of secreted Frizzled-related proteins in
development and disease. J. Cell Sci. 121, 737–746.
Calvi, L.M., Adams, G.B., Weibrecht, K.W., Weber, J.M., Olson, D.P., Knight,
M.C., Martin, R.P., Schipani, E., Divieti, P., Bringhurst, F.R., et al. (2003). Oste-
oblastic cells regulate the haematopoietic stem cell niche. Nature 425,
841–846.
Choong, M.L., Tan, A.C., Luo, B., and Lodish, H.F. (2003). A novel role for pro-
liferin-2 in the ex vivo expansion of hematopoietic stem cells. FEBS Lett. 550,
155–162.
Chung, K.H., Hart, C.C., Al-Bassam, S., Avery, A., Taylor, J., Patel, P.D., Voj-
tek, A.B., and Turner, D.L. (2006). Polycistronic RNA polymerase II expression
vectors for RNA interference based on BIC/miR-155. Nucleic Acids Res. 34,
e53.
Corradi, A., Croci, L., Broccoli, V., Zecchini, S., Previtali, S., Wurst, W.,
Amadio, S., Maggi, R., Quattrini, A., and Consalez, G.G. (2003). Hypogonado-
tropic hypogonadism and peripheral neuropathy in Ebf2-null mice. Develop-
ment 130, 401–410.
Crozatier, M., Ubeda, J.M., Vincent, A., and Meister, M. (2004). Cellular
immune response to parasitization in Drosophila requires the EBF orthologue
collier. PLoS Biol. 2, E196.
DiMascio, L., Voermans, C., Uqoezwa, M., Duncan, A., Lu, D., Wu, J., Sankar,
U., and Reya, T. (2007). Identification of adiponectin as a novel hemopoietic
stem cell growth factor. J. Immunol. 178, 3511–3520.
Dubois, L., and Vincent, A. (2001). The COE–Collier/Olf1/EBF–transcription
factors: Structural conservation and diversity of developmental functions.
Mech. Dev. 108, 3–12.
Duncan, A.W., Rattis, F.M., DiMascio, L.N., Congdon, K.L., Pazianos, G.,
Zhao, C., Yoon, K., Cook, J.M., Willert, K., Gaiano, N., et al. (2005). Integration
of Notch and Wnt signaling in hematopoietic stem cell maintenance. Nat. Im-
munol. 6, 314–322.
Ema, H., Morita, Y., Yamazaki, S., Matsubara, A., Seita, J., Tadokoro, Y.,
Kondo, H., Takano, H., and Nakauchi, H. (2006). Adult mouse hematopoietic
stem cells: Purification and single-cell assays. Nat. Protoc. 1, 2979–2987.
Fleming, H.E., Janzen, V., Lo Celso, C., Guo, J., Leahy, K.M., Kronenberg,
H.M., and Scadden, D.T. (2008). Wnt signaling in the niche enforces hemato-
poietic stem cell quiescence and is necessary to preserve self-renewal in vivo.
Cell Stem Cell 2, 274–283.
Garel, S., Marin, F., Mattei, M.G., Vesque, C., Vincent, A., and Charnay, P.
(1997). Family of Ebf/Olf-1-related genes potentially involved in neuronal differ-
entiation and regional specification in the central nervous system. Dev. Dyn.
210, 191–205.
Goodell, M.A., Brose, K., Paradis, G., Conner, A.S., and Mulligan, R.C. (1996).
Isolation and functional properties of murine hematopoietic stem cells that are
replicating in vivo. J. Exp. Med. 183, 1797–1806.
Hackney, J.A., Charbord, P., Brunk, B.P., Stoeckert, C.J., Lemischka, I.R., and
Moore, K.A. (2002). A molecular profile of a hematopoietic stem cell niche.
Proc. Natl. Acad. Sci. USA 99, 13061–13066.
Hagman, J., Belanger, C., Travis, A., Turck, C.W., and Grosschedl, R. (1993).
Cloning and functional characterization of early B-cell factor, a regulator of
lymphocyte-specific gene expression. Genes Dev. 7, 760–773.
Hattori, K., Heissig, B., and Rafii, S. (2003). The regulation of hematopoietic
stem cell and progenitor mobilization by chemokine SDF-1. Leuk. Lymphoma
44, 575–582.
Jeannet, G., Scheller, M., Scarpellino, L., Duboux, S., Gardiol, N., Back, J.,
Kuttler, F., Malanchi, I., Birchmeier, W., Leutz, A., et al. (2008). Long-term,mul-
tilineage hematopoiesis occurs in the combined absence of beta-catenin and
gamma-catenin. Blood 111, 142–149.
Jimenez, M.A., Akerblad, P., Sigvardsson, M., and Rosen, E.D. (2007). Critical
role for Ebf1 and Ebf2 in the adipogenic transcriptional cascade. Mol. Cell.
Biol. 27, 743–757.
Kiel, M.J., and Morrison, S.J. (2008). Uncertainty in the niches that maintain
haematopoietic stem cells. Nat. Rev. Immunol. 8, 290–301.506 Cell Stem Cell 7, 496–507, October 8, 2010 ª2010 Elsevier Inc.Kiel, M.J., Yilmaz, O.H., Iwashita, T., Terhorst, C., and Morrison, S.J. (2005).
SLAM family receptors distinguish hematopoietic stem and progenitor cells
and reveal endothelial niches for stem cells. Cell 121, 1109–1121.
Kieslinger, M., Folberth, S., Dobreva, G., Dorn, T., Croci, L., Erben, R., Consa-
lez, G.G., and Grosschedl, R. (2005). EBF2 regulates osteoblast-dependent
differentiation of osteoclasts. Dev. Cell 9, 757–767.
Kikuchi, K., and Kondo, M. (2006). Developmental switch of mouse hemato-
poietic stem cells from fetal to adult type occurs in bone marrow after birth.
Proc. Natl. Acad. Sci. USA 103, 17852–17857.
Kim, I., Saunders, T.L., and Morrison, S.J. (2007). Sox17 dependence distin-
guishes the transcriptional regulation of fetal from adult hematopoietic stem
cells. Cell 130, 470–483.
Kim, J.A., Kang, Y.J., Park, G., Kim, M., Park, Y.O., Kim, H., Leem, S.H., Chu,
I.S., Lee, J.S., Jho, E.H., et al. (2009). Identification of a stroma-mediatedWnt/
beta-catenin signal promoting self-renewal of hematopoietic stem cells in the
stem cell niche. Stem Cells 27, 1318–1329.
Kincade, P.W., Oritani, K., Zheng, Z., Borghesi, L., Smithson, G., and Yama-
shita, Y. (1998). Cell interaction molecules utilized in bone marrow. Cell Adhes.
Commun. 6, 211–215.
Kirstetter, P., Anderson, K., Porse, B.T., Jacobsen, S.E., and Nerlov, C. (2006).
Activation of the canonical Wnt pathway leads to loss of hematopoietic stem
cell repopulation and multilineage differentiation block. Nat. Immunol. 7,
1048–1056.
Koch, U., Wilson, A., Cobas, M., Kemler, R., Macdonald, H.R., and Radtke, F.
(2008). Simultaneous loss of beta- and gamma-catenin does not perturb
hematopoiesis or lymphopoiesis. Blood 111, 160–164.
Kondo, M., Weissman, I.L., and Akashi, K. (1997). Identification of clonogenic
common lymphoid progenitors in mouse bone marrow. Cell 91, 661–672.
Krzemien, J., Dubois, L., Makki, R., Meister, M., Vincent, A., and Crozatier, M.
(2007). Control of blood cell homeostasis in Drosophila larvae by the posterior
signalling centre. Nature 446, 325–328.
Lebestky, T., Jung, S.H., and Banerjee, U. (2003). A Serrate-expressing
signaling center controls Drosophila hematopoiesis. Genes Dev. 17, 348–353.
Li, L., and Xie, T. (2005). Stem cell niche: Structure and function. Annu. Rev.
Cell Dev. Biol. 21, 605–631.
Lin, H., and Grosschedl, R. (1995). Failure of B-cell differentiation in mice lack-
ing the transcription factor EBF. Nature 376, 263–267.
Lo Celso, C., Fleming, H.E., Wu, J.W., Zhao, C.X., Miake-Lye, S., Fujisaki, J.,
Cote, D., Rowe, D.W., Lin, C.P., and Scadden, D.T. (2009). Live-animal
tracking of individual haematopoietic stem/progenitor cells in their niche.
Nature 457, 92–96.
Luis, T.C., Weerkamp, F., Naber, B.A., Baert, M.R., de Haas, E.F., Nikolic, T.,
Heuvelmans, S., De Krijger, R.R., van Dongen, J.J., and Staal, F.J. (2009).
Wnt3a deficiency irreversibly impairs hematopoietic stem cell self-renewal
and leads to defects in progenitor cell differentiation. Blood 113, 546–554.
Maillard, I., Koch, U., Dumortier, A., Shestova, O., Xu, L., Sai, H., Pross, S.E.,
Aster, J.C., Bhandoola, A., Radtke, F., and Pear, W.S. (2008). Canonical notch
signaling is dispensable for themaintenance of adult hematopoietic stem cells.
Cell Stem Cell 2, 356–366.
Malgaretti, N., Pozzoli, O., Bosetti, A., Corradi, A., Ciarmatori, S., Panigada,
M., Bianchi, M.E., Martinez, S., and Consalez, G.G. (1997). Mmot1, a new
helix-loop-helix transcription factor gene displaying a sharp expression
boundary in the embryonic mouse brain. J. Biol. Chem. 272, 17632–17639.
Malhotra, S., and Kincade, P.W. (2009). Wnt-related molecules and signaling
pathway equilibrium in hematopoiesis. Cell Stem Cell 4, 27–36.
Malhotra, S., Baba, Y., Garrett, K.P., Staal, F.J., Gerstein, R., and Kincade,
P.W. (2008). Contrasting responses of lymphoid progenitors to canonical
and noncanonical Wnt signals. J. Immunol. 181, 3955–3964.
Mandal, L., Martinez-Agosto, J.A., Evans, C.J., Hartenstein, V., and Banerjee,
U. (2007). A Hedgehog- and Antennapedia-dependent niche maintains
Drosophila haematopoietic precursors. Nature 446, 320–324.
Medina, K.L., Pongubala, J.M., Reddy, K.L., Lancki, D.W., Dekoter, R.,
Kieslinger, M., Grosschedl, R., and Singh, H. (2004). Assembling a gene regu-
latory network for specification of the B cell fate. Dev. Cell 7, 607–617.
Cell Stem Cell
Role of Ebf2 in the Hematopoietic Stem Cell NicheMikkola, H.K., andOrkin, S.H. (2006). The journey of developing hematopoietic
stem cells. Development 133, 3733–3744.
Moore, K.A., and Lemischka, I.R. (2006). Stem cells and their niches. Science
311, 1880–1885.
Moore, K.A., Ema, H., and Lemischka, I.R. (1997). In vitro maintenance of
highly purified, transplantable hematopoietic stem cells. Blood 89, 4337–4347.
Morrison, S.J., Hemmati, H.D., Wandycz, A.M., andWeissman, I.L. (1995). The
purification and characterization of fetal liver hematopoietic stem cells. Proc.
Natl. Acad. Sci. USA 92, 10302–10306.
Murdoch, B., Chadwick, K., Martin, M., Shojaei, F., Shah, K.V., Gallacher, L.,
Moon, R.T., and Bhatia, M. (2003). Wnt-5A augments repopulating capacity
and primitive hematopoietic development of human blood stem cells in vivo.
Proc. Natl. Acad. Sci. USA 100, 3422–3427.
Nemeth, M.J., Topol, L., Anderson, S.M., Yang, Y., and Bodine, D.M. (2007).
Wnt5a inhibits canonical Wnt signaling in hematopoietic stem cells and
enhances repopulation. Proc. Natl. Acad. Sci. USA 104, 15436–15441.
Nemeth, M.J., Mak, K.K., Yang, Y., and Bodine, D.M. (2009). beta-Catenin
expression in the bone marrow microenvironment is required for long-term
maintenance of primitive hematopoietic cells. Stem Cells 27, 1109–1119.
Phillips, R.L., Ernst, R.E., Brunk, B., Ivanova, N., Mahan, M.A., Deanehan, J.K.,
Moore, K.A., Overton, G.C., and Lemischka, I.R. (2000). The genetic program
of hematopoietic stem cells. Science 288, 1635–1640.
Ploemacher, R.E., van der Sluijs, J.P., van Beurden, C.A., Baert, M.R., and
Chan, P.L. (1991). Use of limiting-dilution type long-term marrow cultures in
frequency analysis of marrow-repopulating and spleen colony-forming hema-
topoietic stem cells in the mouse. Blood 78, 2527–2533.
Renstrom, J., Istvanffy, R., Gauthier, K., Shimono, A., Mages, J., Jardon-Al-
varez, A., Kroger, M., Schiemann, M., Busch, D.H., Esposito, I., et al. (2009).
Secreted frizzled-related protein 1 extrinsically regulates cycling activity and
maintenance of hematopoietic stem cells. Cell Stem Cell 5, 157–167.
Reya, T., Duncan, A.W., Ailles, L., Domen, J., Scherer, D.C., Willert, K., Hintz,
L., Nusse, R., and Weissman, I.L. (2003). A role for Wnt signalling in self-
renewal of haematopoietic stem cells. Nature 423, 409–414.CSacchetti, B., Funari, A., Michienzi, S., Di Cesare, S., Piersanti, S., Saggio, I.,
Tagliafico, E., Ferrari, S., Robey, P.G., Riminucci, M., et al. (2007). Self-renew-
ing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic
microenvironment. Cell 131, 324–336.
Scheller, M., Huelsken, J., Rosenbauer, F., Taketo, M.M., Birchmeier, W.,
Tenen, D.G., and Leutz, A. (2006). Hematopoietic stem cell and multilineage
defects generated by constitutive beta-catenin activation. Nat. Immunol. 7,
1037–1047.
Staal, F.J., Luis, T.C., and Tiemessen, M.M. (2008). WNT signalling in the
immune system: WNT is spreading its wings. Nat. Rev. Immunol. 8, 581–593.
Suda, T., Arai, F., and Hirao, A. (2005). Hematopoietic stem cells and their
niche. Trends Immunol. 26, 426–433.
Sugiyama, T., Kohara, H., Noda, M., and Nagasawa, T. (2006). Maintenance of
the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in
bone marrow stromal cell niches. Immunity 25, 977–988.
Taichman, R.S. (2005). Blood and bone: Two tissues whose fates are inter-
twined to create the hematopoietic stem-cell niche. Blood 105, 2631–2639.
Tokoyoda, K., Egawa, T., Sugiyama, T., Choi, B.I., and Nagasawa, T. (2004).
Cellular niches controlling B lymphocyte behavior within bone marrow during
development. Immunity 20, 707–718.
Xie, Y., Yin, T., Wiegraebe, W., He, X.C., Miller, D., Stark, D., Perko, K.,
Alexander, R., Schwartz, J., Grindley, J.C., et al. (2009). Detection of functional
haematopoietic stem cell niche using real-time imaging. Nature 457, 97–101.
Yokota, T., Oritani, K., Garrett, K.P., Kouro, T., Nishida, M., Takahashi, I., Ichii,
M., Satoh, Y., Kincade, P.W., and Kanakura, Y. (2008). Soluble frizzled-related
protein 1 is estrogen inducible in bone marrow stromal cells and suppresses
the earliest events in lymphopoiesis. J. Immunol. 181, 6061–6072.
Zhang, J., Niu, C., Ye, L., Huang, H., He, X., Tong, W.G., Ross, J., Haug, J.,
Johnson, T., Feng, J.Q., et al. (2003). Identification of the haematopoietic
stem cell niche and control of the niche size. Nature 425, 836–841.ell Stem Cell 7, 496–507, October 8, 2010 ª2010 Elsevier Inc. 507
